About
Technology
Therapeutics
Partnering
Careers
Newsroom
Contact
Twitter
Linkedin
info@bighatbio.com
About
About
Technology
Technology
Therapeutics
Therapeutics
Partnering
Partnering
Careers
Careers
Newsroom
Newsroom
Twitter
Twitter
Linkedin
Linkedin
Contact Us
The Latest
Newsroom
All
Announcements
Press
Publications
Presentations
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
4.24.2024
BigHat Biosciences Enters into Strategic Collaboration to Leverage Machine Learning in Antibody Discovery & Design
Press
12.5.2023
AbbVie and BigHat Biosciences Announce Research Collaboration to Leverage Artificial Intelligence and Machine Learning to Discover Next-Generation Therapeutic Antibodies
Press
Recent Posts
3.1.2021
BigHat CSO on the future of machine learning and computational biology at Stanford Computer Science AI Salon
Announcements
2.10.2021
BigHat Biosciences Raises $19 Million in Series A Funding to Advance Antibody Design and Development for Safer, More Effective Treatments
Announcements
12.14.2020
Antibody developer Steve Doberstein joins BigHat advisory team
Announcements
11.18.2020
Peyton Greenside, BigHat CSO, speaks about machine-guided biological design
Announcements
11.1.2020
BigHat Biosciences earns Phase I award from NIST to show power of AI-driven platform
Announcements
9.15.2020
BigHat awarded 2020 Golden Ticket from Amgen and MBC Biolabs
Announcements
8.12.2020
BigHat founder discusses COVID-19's impact on early-stage startups
Announcements
7.18.2020
BigHat founder presents active learning innovations at ICML 2020
Announcements
6.9.2020
BigHat founder speaks at the annual European Society for Human Genetics (ESHG) 2020 meeting
Announcements
4.30.2020
BigHat founder talks leading interdisciplinary teams with Stanford Accel Scholars
Announcements
12.4.2019
BigHat founder at the Cell Free Systems conference
Announcements
11.11.2019
BigHat founder moderates Deep Life salon
Announcements
Previous
4 / 5
Next
© BigHat Bio 2023